Valiant Laboratories Limited
ListedMainboardIndustrial & Financial Services · NSE / BSE
Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.
Price Band
₹133 – ₹140
Issue Size
₹152 Cr
Lot Size
105 shares
GMP
₹20
+14.3%
Est. Listing
₹160
at current GMP
Subscribed
29.75x
overall
Open
27 Sep 2023
Close
3 Oct 2023
Allotment
4 Oct 2023
Refund
5 Oct 2023
Demat Credit
6 Oct 2023
Listing
6 Oct 2023
Last updated 12 days ago
Overall Subscription
29.75x
Total Demand
QIB Multiplier
20.83x
Institutions & Funds
NII / HNI
73.63x
High Net-Worth
Retail (RII)
16.05x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 2,178,030 | 45,361,155 | 20.83x |
| NIB | 1,633,500 | 120,280,965 | 73.63x |
| HNIs(10L +) | 1,088,999 | 85,636,635 | 78.64x |
| HNIs (2-10L) | 544,501 | 34,644,330 | 63.63x |
| RETAIL | 3,811,500 | 61,170,900 | 16.05x |
| Total | 9,256,530 | 347,093,985 | 29.75x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 36,190 | 580,850 | 16.05x |
| HNIs (10L +) | 231 | 17,009 | 73.63x |
| HNIs (2-10L) | 1,108 | 81,582 | 73.63x |
| Total Applications | 37,529 | 679,441 | 18.10x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Valiant Laboratories Limited Public Issue & Market Profile
Valiant Laboratories Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹152 Crores. The shares are offered at a price band of ₹133 to ₹140 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2023-10-03, the basis of allotment is scheduled to be finalized on 2023-10-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Valiant Laboratories Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Valiant Laboratories Limited IPO is ₹20 per equity share. Based on the upper price band of ₹133 to ₹140 per equity share, the estimated listing price is ₹160 (+14.3% expected listing gain).
What is the expected profit per lot for Valiant Laboratories Limited IPO?
With a lot size of 105 shares and current GMP of ₹20, the expected profit per application lot is approx ₹2,100 (+14.3% gain). Minimum application cost is approx ₹14,700.
What is the issue size and price band for Valiant Laboratories Limited IPO?
The Valiant Laboratories Limited IPO aggregate issue size is ₹152 Crores with an equity price band set at ₹133 to ₹140 per equity share. The retail lot size is 105 shares requiring a minimum capital outlay of approx. ₹14,700.
How can I check Valiant Laboratories Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 29.75x (Retail: 16.05x, QIB: 20.83x, NII: 73.63x). You can track live multiples directly on our dedicated subscription page.
Where and when will Valiant Laboratories Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2023-10-04. Investors can verify status using PAN card or application number.
When is the listing date for Valiant Laboratories Limited IPO?
Valiant Laboratories Limited shares are scheduled to list on NSE and BSE on 2023-10-06.